Prospective development and validation of a liquid immune profile-based signature (LIPS) to predict response of metastatic cancer patients to immune checkpoint inhibitors

Jian-Guo Zhou, Anna-Jasmina Donaubauer, Benjamin Frey, Ina Becker, Sandra Rutzner, Markus Eckstein, Roger Sun, Hu Ma, Philipp Schubert, Claudia Schweizer, Rainer Fietkau, Eric Deutsch, Udo S. Gaipl, Markus Hecht
doi: https://doi.org/10.1101/2020.08.03.20167163

Article usage

Article usage: August 2020 to December 2024

AbstractFullPdf
Aug 2020302099
Sep 202057024
Oct 2020260658
Nov 202057822
Dec 202068828
Jan 202145733
Feb 2021721212
Mar 202166118
Apr 2021972019
May 2021771215
Jun 202164810
Jul 202138613
Aug 2021301119
Sep 202133320
Oct 202125219
Nov 202133433
Dec 202123612
Jan 202216613
Feb 20222116
Mar 20221613
Apr 20221919
May 202223718
Jun 20221738
Jul 202212110
Aug 202218415
Sep 20223056
Oct 202222211
Nov 202214216
Dec 202214614
Jan 202323310
Feb 20231657
Mar 20231112
Apr 202330312
May 202311215
Jun 2023675
Jul 20231509
Aug 202315138
Sep 20231479
Oct 20231014
Nov 20231696
Dec 2023802
Jan 2024944
Feb 20241236
Mar 202412410
Apr 20241379
May 2024538
Jun 202411415
Jul 20249111
Aug 20241547
Sep 202418210
Oct 2024666
Nov 202411118
Dec 2024517
Back to top
Posted October 02, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Prospective development and validation of a liquid immune profile-based signature (LIPS) to predict response of metastatic cancer patients to immune checkpoint inhibitors
Jian-Guo Zhou, Anna-Jasmina Donaubauer, Benjamin Frey, Ina Becker, Sandra Rutzner, Markus Eckstein, Roger Sun, Hu Ma, Philipp Schubert, Claudia Schweizer, Rainer Fietkau, Eric Deutsch, Udo S. Gaipl, Markus Hecht
medRxiv 2020.08.03.20167163; doi: https://doi.org/10.1101/2020.08.03.20167163
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area